Afatinib-related nonhematologic adverse events: Is common evaluation enough for now?

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	864-865
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	32
Issue number	8
DOIs	https://doi.org/10.1200/JCO.2013.52.4538
Publication status	Published - Mar 10 2014

ASJC Scopus subject areas

@article{622bcc35fdf9438fb0d68fcb7b0f4341,

title = "Afatinib-related nonhematologic adverse events: Is common evaluation enough for now?",

author = "Filippode Marinis and Antonio Passaro",

year = "2014",

month = mar,

day = "10",

doi = "10.1200/JCO.2013.52.4538",

language = "English",

volume = "32",

pages = "864--865",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "8",

}

TY - JOUR

T1 - Afatinib-related nonhematologic adverse events

T2 - Is common evaluation enough for now?

AU - Marinis, Filippode

AU - Passaro, Antonio

PY - 2014/3/10

Y1 - 2014/3/10

UR - http://www.scopus.com/inward/record.url?scp=84899671129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899671129&partnerID=8YFLogxK

U2 - 10.1200/JCO.2013.52.4538

DO - 10.1200/JCO.2013.52.4538

M3 - Article

C2 - 24493732

AN - SCOPUS:84899671129

VL - 32

SP - 864

EP - 865

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 8

ER -